The Caretaker4 product has already secured approval from the US Food and Drug Administration (FDA) to measure ICU quality continuous beat-by-beat blood pressure, heart rate, SP02 and body temperature.
The Caretaker 4 helps streamline clinician workflow and enhances patient comfort as well as safety with its ability to measure continuous blood pressure and vital signs without bulky external arm cuffs.
In addition, the ability of Caretakers to send patient data to several monitoring platforms, enables the Caretaker 4 to be integrated onto various OEM solutions.
The wearable Caretaker4 monitor allows wire-free and electrode-free real-time vital signs monitoring without any interruption across the full continuum of care, starting from clinic and hospital, to patient transport and home monitoring after discharge.
Using a low-pressure finger cuff, Caretakers patented Pulse Decomposition Analysis technology non-invasively measures continuous Beat-by-Beat blood pressure as accurately as an invasive arterial catheter, the company said.
It also measures heart rate as accurately as a 3-lead ECG for remote display on the Caretaker tablet app, secure web portal or other wireless devices.
Caretaker Medical EMEA APAC regions managing director Warren Kressinger-Dunn said: “The Caretaker4 wearable vital signs device sets a new standard in monitoring patients’ Continuous Blood Pressure and vital signs, either in hospital or remote monitoring situations.
“Caretaker has clear benefits over traditional intermittent spot check methods, offering a clear alternative to invasive arterial catheters or expensive bulky vital signs monitoring equipment. The CE compliance of Caretaker4 is another important stage of growth for Caretaker Medical and allows further expansion into the key EMEA and APAC markets.”
Recently, the company secured $3.4m of investment in a round led by IrishAngels, KOFA Healthcare and Jaffray Woodriff (executed by his family office, Felton Group).
Proceeds from this investment will be used to accelerate the company’s global commercialization activities for the Caretaker4 wireless CNIBP Vital signs monitor.
